A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.

Martin J Van Den BentAnalia AzaroFilip De VosJuan SepulvedaW K Alfred YungPatrick Y WenAndrew B LassmanMarkus JoergerGhazaleh TabatabaiJordi RodonRalph TiedtSylvia ZhaoTiina KirsilaeYi ChengSergio VicenteO Alejandro BalbinHefei ZhangWolfgang Wick

Published in: Journal of neuro-oncology (2019)

NCT01870726.

Keyphrases

open label
clinical trial
phase ii
phase iii
phase ii study
study protocol
squamous cell carcinoma
radiation therapy